AdoraPet Biosciences
Early Stage
Invest in Pets that don't cause allergies
Overview
Platform
Dealmaker Securities
Start Date
12/19/2022
Close Date
04/23/2023
Min. Goal
$50,000
Max. Goal
$5,000,000
Min. Investment
$1,000
Security Type
Equity - Common
Series
Pre-Seed
Funding Type
RegCF
Price Per Share
$5.00
Pre-Money Valuation
$35,000,000
Location
San Mateo, California
Industry
Pet Health, Food, and Services
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Low
Capital Intensity
High
AdoraPet Biosciences, with a valuation of $20 million, is raising funds on DealMaker Securities. The company’s goal is to allow pets and owners to spend more time together by using state-of-the-art gene technology to eliminate the genes that cause allergies in owners and diseases in our pets. CRISPR is a Nobel Prize-winning technology scientists can use to remove problem-causing genes. AdoraPet plans to use CRISPR technology to modify these genes in embryos, creating allergy-free, long-living pets for everyone. Dr. Richard Chin, Dr. Stephen Sundlof and Dr. George Church founded AdoraPet in 2022. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5,000,000.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$0 |
$0 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$560 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$560 |
$0 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Financials as of: 12/19/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
